SmartScan (Decision/Risk Analysis) Overview
- Year Founded
-
2017
- Status
-
Acquired/Merged
- Employees
-
10
- Latest Deal Type
-
M&A
SmartScan (Decision/Risk Analysis) General Information
Description
Developer of diagnostic tools designed to simplify the medical examination process. The company's tools specialize in AI-based image recognition technology that examines the current condition of a patient's brain, enabling domestic and overseas brain dock clinics to prevent the onset of cerebrovascular diseases through the use of a telemedicine system.
Contact Information
Website
www.smartscan.co.jp(Operating Subsidiary)
Corporate Office
- 19th floor, Kasumigaseki Building
- 3-2-5 Kasumigaseki, Chiyoda-ku
- Tokyo, 100-6019
- Japan
Corporate Office
- 19th floor, Kasumigaseki Building
- 3-2-5 Kasumigaseki, Chiyoda-ku
- Tokyo, 100-6019
- Japan
SmartScan (Decision/Risk Analysis) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 18-Dec-2023 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series B) | 11-Apr-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 23-Jun-2021 | $10.4M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 22-Nov-2019 | $10.4M | $10.4M | Completed | Generating Revenue |
SmartScan (Decision/Risk Analysis) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
SmartScan (Decision/Risk Analysis) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
SmartScan (Decision/Risk Analysis) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
SmartScan (Decision/Risk Analysis) Former Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aflac Ventures Japan | Venture Capital | Minority | ||
| Canon Medical Systems | Corporation | Minority | ||
| Credit Saison | Lender/Debt Provider | Minority | ||
| Cyberdyne | Corporation | Minority | ||
| DG Ventures | Corporate Venture Capital | Minority |
SmartScan (Decision/Risk Analysis) FAQs
-
When was SmartScan (Decision/Risk Analysis) founded?
SmartScan (Decision/Risk Analysis) was founded in 2017.
-
Where is SmartScan (Decision/Risk Analysis) headquartered?
SmartScan (Decision/Risk Analysis) is headquartered in Tokyo, Japan.
-
What is the size of SmartScan (Decision/Risk Analysis)?
SmartScan (Decision/Risk Analysis) has 10 total employees.
-
What industry is SmartScan (Decision/Risk Analysis) in?
SmartScan (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.
-
Is SmartScan (Decision/Risk Analysis) a private or public company?
SmartScan (Decision/Risk Analysis) is a Private company.
-
What is SmartScan (Decision/Risk Analysis)’s current revenue?
The current revenue for SmartScan (Decision/Risk Analysis) is .
-
How much funding has SmartScan (Decision/Risk Analysis) raised over time?
SmartScan (Decision/Risk Analysis) has raised $21.7M.
-
Who are SmartScan (Decision/Risk Analysis)’s investors?
Aflac Ventures Japan, Canon Medical Systems, Credit Saison, Cyberdyne, and DG Ventures are 5 of 12 investors who have invested in SmartScan (Decision/Risk Analysis).
-
When was SmartScan (Decision/Risk Analysis) acquired?
SmartScan (Decision/Risk Analysis) was acquired on 18-Dec-2023.
-
Who acquired SmartScan (Decision/Risk Analysis)?
SmartScan (Decision/Risk Analysis) was acquired by Eucalia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
